A Pilot Study of Bevacizumab for Neoplastic Meningitis

NCT00924820 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Neoplastic Meningitis

Interventions

DRUG: Bevacizumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]